Stryker Buys OEM Partner Gaymar Industries For $150 Million
This article was originally published in The Gray Sheet
Executive Summary
Stryker is acquiring support surface and pressure ulcer management company Gaymar Industries, with which it has had a long-time marketing arrangement, for $150 million, the firm announced Aug. 24
You may also be interested in...
Stryker may be candidate for Boston Sci neuromodulation biz
Stryker is reportedly in talks to acquire Boston Scientific's neuromodulation business for about $1.5 billion, although neither firm has publicly confirmed the discussions. Bloomberg reported Aug. 17 that the talks were in "advanced" stages. The Boston Sci neuromodulation biz, which makes spinal cord stimulation implants for pain management, would make "a good strategic fit" for Stryker's roughly $600 million spinal implant business and smaller pain management business, Wells Fargo Securities analyst Michael Matson said in an Aug. 18 report. Boston's neuromodulation sales increased 17% to $285 million in 2009. Reports first surfaced in April that Boston was considering selling its neuromodulation and neurovascular businesses. While neuromodulation has been Boston Scientific's fastest growing unit, the company may be willing to sell because of competitive pressures from Medtronic and St. Jude Medical and the investment that would be needed to catch up, some analysts say 1("The Gray Sheet" April 19, 2010)
New EU Approvals
The Pink Sheet's list of EU centralized approvals of new active substances has been updated to add two new products, including Ryzneuta, Evive Biotechnology's treatment for chemotherapy-induced neutropenia.
Pair Of Deaths Linked To Recalled Vyaire Medical Respiratory Devices
The US FDA has labelled a recall of more than 6 million Airlife respiratory support devices class I. The recall covers devices manufactured in 2017 or earlier that can fail to provide adequate ventilation.